Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 11

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 11
---
 interest may not be exchanged for certificated securities, except in limited circumstances.

S-6

#### TABLE OF CONTENTS
**Certain Material U.K. and U.S. Federal Income Tax Consequences**

For a discussion of certain material U.K. and U.S. federal income tax consequences of the purchase, holding, disposition and conversion of the notes, and the holding and disposition of the ADSs into which the notes may be converted, and the ordinary shares represented by such ADSs, see the section titled “Taxation.”

**Trustee, Paying Agent, Security Registrar and Conversion Agent

U.S. Bank Trust Company, National Association.**

<div align='center'>S-7</div>

TABLE OF CONTENTS

RISK FACTORS Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks discussed under the section captioned “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on February 26, 2025 and in our other filings that are incorporated by reference in this prospectus supplement and the accompanying base prospectus, together with the other information in this prospectus supplement and the accompanying base prospectus, the documents incorporated by reference herein and therein, and in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be seriously harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also read carefully the section below entitled “Special Note Regarding Forward-Looking Statements.” Risks Related to the Notes The notes are effectively subordinated to any of our secured debt and structurally junior to all debt and other liabilities of our subsidiaries. The notes are our general unsecured obligations and rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the notes; equal in right of payment with all of our existing and future liabilities that are not so subordinated; effectively junior to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of our current or future subsidiaries. In the event of our bankruptcy, liquidation, reorganization or other winding up, our assets that secure indebtedness ranking